Family Medicine · San Bernardino, CA
NPI
1568494151
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1800 Western Ave, Suite 401
San Bernardino, CA, 92411
Phone (909) 880-3677
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
198 services
Medicare patients, 2024
41
Average age 70
Drug cost, 2024
$2.7M
25,570 prescriptions
Company payments, 2025
$2,894
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel Franco was code 99214 (office e&m - established), 71 times for 29 patients. In total Daniel Franco billed 198 services in 18 codes, and Medicare paid $11K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 71 | 29 | $92.05 | $6,536 |
| 99213 Office E&M - Established | Office | 33 | 20 | $58.55 | $1,932 |
| 82962 Clinical Chemistry | Office | 23 | 12 | $3.21 | $73.83 |
By year: 2022 $15K for 393 services; 2023 $10K for 229 services; 2024 $11K for 198 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 23 | 12 | $3.21 | $73.83 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Franco prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,860 prescriptions and refills. In total Daniel Franco wrote 25,570 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,860 | 5,028 | 611 | $21K |
| Metformin Hcl Generic | 1,121 | 2,897 | 351 | $8,057 |
| Losartan Potassium Generic | 860 | 2,244 | 277 | $8,877 |
| Levothyroxine Sodium Generic | 735 | 1,823 | 217 | $9,792 |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 698 | 1,868 | 212 | $11K |
| Omeprazole Generic | 686 | 1,543 | 209 | $9,614 |
| Gabapentin Generic | 685 | 1,062 | 180 | $6,202 |
| Amlodipine Besylate Generic | 670 | 1,797 | 227 | $3,701 |
| Tamsulosin Hcl Generic | 585 | 1,491 | 188 | $8,349 |
| Rosuvastatin Calcium Generic | 563 | 1,421 | 195 | $9,168 |
| Pantoprazole Sodium Generic | 454 | 895 | 130 | $4,163 |
| Lisinopril Generic | 409 | 1,129 | 140 | $2,740 |
| Tramadol Hcl Generic | 400 | 407 | 123 | $2,301 |
| Ibuprofen Generic | 378 | 456 | 119 | $3,144 |
| Simvastatin Generic | 378 | 996 | 114 | $3,034 |
Brand drugs: 3,765 claims; generic drugs: 21,337 claims; opioid claims: 403.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Franco $2,894 ($2,894 in general payments such as food, travel and fees) from 25 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $443.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 15 | $443 |
| Amgen Inc. AMGN | 25 | $321 |
| Abbott Laboratories ABT | 10 | $308 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 11 | $282 |
| Merck Sharp & Dohme LLC MRK | 5 | $223 |
| Pfizer Inc. PFE | 5 | $223 |
| Novo Nordisk Inc NVO | 10 | $195 |
| Lilly USA, LLC LLY | 10 | $153 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $96.86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $85.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.